JMP Securities cut shares of Notable Labs (NASDAQ:NTBL – Free Report) from an outperform rating to a market perform rating in a research report released on Friday, MarketBeat Ratings reports.
Notable Labs Trading Down 6.0 %
NASDAQ:NTBL opened at $0.45 on Friday. Notable Labs has a twelve month low of $0.40 and a twelve month high of $10.08. The company has a quick ratio of 2.77, a current ratio of 2.77 and a debt-to-equity ratio of 0.03. The business has a 50 day moving average price of $0.56 and a two-hundred day moving average price of $0.90.
Notable Labs (NASDAQ:NTBL – Get Free Report) last announced its quarterly earnings data on Wednesday, August 14th. The company reported ($0.55) EPS for the quarter. Equities analysts predict that Notable Labs will post -0.75 earnings per share for the current year.
About Notable Labs
Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment.
See Also
- Five stocks we like better than Notable Labs
- What is a Stock Market Index and How Do You Use Them?
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- Election Stocks: How Elections Affect the Stock Market
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- What Investors Need to Know to Beat the Market
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for Notable Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Notable Labs and related companies with MarketBeat.com's FREE daily email newsletter.
